Hypersensitivity: Clinical Trials

70 trials for Hypersensitivity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed, 8 unknown, 7 terminated, 4 enrolling by invitation. 70 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 170Completed 43, Unknown 8, Terminated 7, Enrolling by invitation 4, Active not recruiting 3, Recruiting 3, Not yet recruiting 1, Withdrawn 1

Follow Hypersensitivity: new trials by email Literature Review of Hypersensitivity trials Research Report on Hypersensitivity

Trials (filtered) newest first · largest first

All 70 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of HRS-3095 in Healthy Volunteers
HRS-3095 - Chronic Spontaneous Urticaria
Early Phase 1RecruitingAtridia Pty Ltd.362026-07-272026-08-07
LYmph Node eXamination in Cat Allergen Immunotherapy
Intradermal cat allergen challenge - Allergy
Early Phase 1RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)162026-04-102026-05-01
An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga-SFB6-ZN01, in Patients With Malignant Tumors
68Ga-SFB6-ZN01 - Neoplasms
Early Phase 1Not yet recruitingZhongnan Hospital982026-03-102026-03-03
Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.
Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT], budesonide oral suspension - Eosinophilic Esophagitis (EoE)
Early Phase 1Enrolling by invitationMayo Clinic602026-02-042026-05-04
Thera-Clean® Microbubbles System in Patients With Skin Diseases
TheraClean - Epidermolysis Bullosa, Ichthyosis
Early Phase 1Enrolling by invitationNorthwestern University202026-01-132026-02-03
Effectiveness of 1st Rib Mobilization and Scalene Muscles Muscle Energy Technique Among Patients With Asthma
First Rib Mobilization + Respiratory Physiotherapy, Scalene Muscle Energy Technique (MET) + Respiratory Physiotherapy - Asthma
Early Phase 1Active not recruitingSuperior University472025-03-042025-06-25
Combination of Oral Supplement With Fatty Acids, Vitamin B6, Perilla, and Liquorice With Nasal Steroids for the Treatment of Allergic Rhinitis
Oral fatty acid, Mometasone Furoate Nasal Spray (MFNS) - Allergic Rhinitis
Early Phase 1CompletedIsola Tiberina - Gemelli Isola Hospital, Rome, Italy4002024-09-012025-06-12
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Magnesium Sulfate within the first hour, No Magnesium sulfate within the first hour - Asthma in Children, Asthma Attack
Early Phase 1RecruitingUniversity of Oklahoma1002023-11-302024-12-06
Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study
Polvac Grass+Rye - Hypersensitivity, Hay Fever
Early Phase 1CompletedUniversity of Zurich282023-11-232025-05-21
Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis
High-intensity focused ultrasound (HIFU), intranasal corticosteroids, oral antihistamines, oral leukotriene receptor antagonists, and intranasal antihistamines - Allergic Rhinitis
Early Phase 1UnknownChongqing Medical University2402023-08-012024-02-22
Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis
Abrocitinib, Tofacitinib - Toxic Epidermal Necrolysis
Early Phase 1UnknownPeng Zhang302023-07-052023-11-28
Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis
Caffeine, Metoprolol, Midazolam - Atopic Dermatitis
Early Phase 1CompletedAmgen212023-06-032025-12-23
Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis
GD-iExo-001, normal saline - Atopic Dermatitis
Early Phase 1UnknownPeking Union Medical College Hospital202023-04-122023-08-01
Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers
Montelukast Oral Tablet - Allergic Rhinitis
Early Phase 1UnknownAssiut University602022-10-012022-05-19
IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
Dupilumab, Photo therapy - Atopic Dermatitis
Early Phase 1CompletedMayo Clinic72022-08-092024-02-26
FAPI PET for Lung Fibrosis
68Ga-FAPi-46, Computed Tomography, Positron Emission Tomography - Interstitial Lung Disease, Idiopathic Interstitial Pneumonias
Early Phase 1Active not recruitingUniversity of California, Los Angeles302021-11-162026-08-20
Cyclosporine Vs Steroids in DRESS
Cyclosporine, Methylprednisolone and Prednisone - DRESS Syndrome, Drug-Induced Hypersensitivity Syndrome
Early Phase 1Enrolling by invitationUniversity of Southern California502021-09-272025-03-30
Gastrointestinal STRING Test With Oral Immunotherapy
Entero-tracker, omalizumab, dupliumab - Eosinophilic Disorder, Food Allergy
Early Phase 1TerminatedStanford University132021-05-172024-09-19
Characterizing Skin Microbiome Change in Atopic Dermatitis
Crisaborole 2% Top Oint, Skin Microbiome Swabs - Atopic Dermatitis, Atopic Dermatitis Eczema
Early Phase 1CompletedUniversity of California, Irvine202021-03-232024-02-02
Effectiveness of a Mobile Health Intervention in Improving the Technique of Inhaled Medications Among Children With Asthma
BreatheSuite - Asthma, Asthma in Children
Early Phase 1CompletedMemorial University of Newfoundland302021-01-012022-04-08

Showing 20 of 70. Sign in to see all of them.

Narrower conditions

Asthma (25)  ·  Dermatitis, Atopic (12)  ·  Pulmonary Disease, Chronic Obstructive (5)  ·  Rhinitis, Allergic (5)  ·  Chronic Urticaria (3)  ·  Eosinophilic Esophagitis (3)  ·  Food Hypersensitivity (3)  ·  Milk Hypersensitivity (3)  ·  Rhinitis, Allergic, Seasonal (3)  ·  Lung Diseases, Interstitial (2)  ·  Peanut Hypersensitivity (2)  ·  Psoriasis (2)  ·  Pulmonary Fibrosis (2)  ·  Sarcoidosis (2)

Broader conditions

Immune System Diseases (69)  ·  Hypersensitivity, Immediate (57)  ·  Respiratory Tract Diseases (35)  ·  Respiratory Hypersensitivity (33)  ·  Lung Diseases (27)  ·  Bronchial Diseases (25)  ·  Lung Diseases, Obstructive (24)  ·  Skin and Connective Tissue Diseases (19)  ·  Skin Diseases (18)  ·  Dermatitis (15)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (14)  ·  Genetic Diseases, Inborn (14)  ·  Skin Diseases, Eczematous (13)  ·  Skin Diseases, Genetic (12)

Interventions

montelukast (6)  ·  Budesonide (2)  ·  Mannitol (2)  ·  Omalizumab (2)  ·  Saline Solution (2)  ·  dupilumab (2)  ·  Antigens, Dermatophagoides (1)  ·  Caffeine (1)  ·  Calcium Dobesilate (1)  ·  Complement C1 Inhibitor Protein (1)  ·  Cyclosporine (1)  ·  Diphenhydramine (1)  ·  Dobutamine (1)  ·  Drugs, Generic (1)  ·  Endoscopy, Digestive System (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Mayo Clinic (4)  ·  Roxane Laboratories (4)  ·  Hamilton Health Sciences Corporation (2)  ·  Janssen Research & Development, LLC (2)  ·  University of North Carolina, Chapel Hill (2)  ·  University of Oklahoma (2)  ·  Ace Cells Lab Limited (1)  ·  Amgen (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Assiut University (1)  ·  Atridia Pty Ltd. (1)  ·  Beijing Tongren Hospital (1)  ·  Boston Children's Hospital (1)  ·  Centre Hospitalier Universitaire de Besancon (1)

Countries

United States (42)  ·  Canada (7)  ·  China (5)  ·  United Kingdom (3)  ·  France (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Australia (1)  ·  Belgium (1)  ·  Denmark (1)  ·  Israel (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Pakistan (1)  ·  Romania (1)

Top investigators

Alan K Copa, PharmD (4)  ·  Gail Gauvreau, PhD (2)  ·  Hugh A. Sampson, MD (2)  ·  Paul O'Byrne, MD (2)  ·  Amin Javer, MD (1)  ·  Amy Paller, MD (1)  ·  Anna Nowak-Wegrzyn, MD (1)  ·  Antonella Cianferoni, MD, PhD (1)  ·  Barbara W. Carlson, RN, Ph.D. (1)  ·  Carolyn Baloh, M.D. (1)  ·  Christine A Sorkness, Pharm.D. (1)  ·  Corinne Keet, MD, PhD (1)  ·  Dale Umetsu, MD (1)

Results publications

PMID 19001265, PMID 22318492, PMID 27978840, PMID 30846271, PMID 32679209, PMID 32883677, PMID 33099797, PMID 35584850, PMID 35691614, PMID 35762891, PMID 37945413, PMID 39362770, PMID 39837697

NIH funding

2023 (1), P01HL158507 (1), R01HL122424 (1), R01HL135235 (1), R61AT009989 (1), UL1TR001412 (1)